Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Opto Circuits (India)'s Debt-to-EBITDA or its related term are showing as below:
NSE:OPTOCIRCUI's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.6 * Ranked among companies with meaningful Debt-to-EBITDA only.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Opto Circuits (India) Debt-to-EBITDA Related Terms
Opto Circuits (India) Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Opto Circuits (India)'s Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:OPTOCIRCUI vs ABT, MDT, SYK: Debt-to-EBITDA Comparison
For the Medical Devices subindustry, Opto Circuits (India)'s Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Opto Circuits (India) Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Opto Circuits (India)'s Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Opto Circuits (India)'s Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2021) EBITDA data.
Opto Circuits (India) (NSE:OPTOCIRCUI) has a Debt-to-EBITDA of 0.00 as of Jun. 2021. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Opto Circuits (India).
Is Opto Circuits (India)'s Debt-to-EBITDA too high?
Opto Circuits (India)'s current Debt-to-EBITDA is 0.00. Overall, Opto Circuits (India) has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Opto Circuits (India)'s Debt-to-EBITDA compare to ABT and MDT?
Opto Circuits (India)'s Debt-to-EBITDA of 0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median Debt-to-EBITDA is 1.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.60, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Opto Circuits (India). For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Opto Circuits (India)'s current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Opto Circuits (India) stock overvalued right now?
Opto Circuits (India) (NSE:OPTOCIRCUI) has a current Debt-to-EBITDA of 0.00. The current Debt-to-EBITDA is 0.00. Opto Circuits (India)'s overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Opto Circuits (India) (NSE:OPTOCIRCUI), the current Debt-to-EBITDA is 0.00 as of Jun. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Opto Circuits (India) Ltd along with its subsidiaries are engaged in the design, development, manufacture, marketing, and distribution of a range of medical products. The company's product is used by the healthcare industry, schools, and fire stations. The service line of the company consists of providing vital signs monitoring, emergency cardiac care, vascular treatments, and sensing technologies. The business of the company operates in segments that include Sensors, Monitors, and Others. The Sensors segment generates maximum revenue for the company. Geographically the company exports its products to America, Europe, and Asia markets.
4GF Score
Get the complete analysis for NSE:OPTOCIRCUI
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:OPTOCIRCUI has been successfully added to your 
